Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Are we ready to adopt the European Association of Urology recommendations on multiparametric magnetic resonance imaging in the early detection of prostate cancer?

Thangasamy IA, Alghazo O, Murphy DG.

Investig Clin Urol. 2019 Jul;60(4):225-226. doi: 10.4111/icu.2019.60.4.225. Epub 2019 May 29. No abstract available.

2.

What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.

Moldovan PC, Van den Broeck T, Sylvester R, Marconi L, Bellmunt J, van den Bergh RCN, Bolla M, Briers E, Cumberbatch MG, Fossati N, Gross T, Henry AM, Joniau S, van der Kwast TH, Matveev VB, van der Poel HG, De Santis M, Schoots IG, Wiegel T, Yuan CY, Cornford P, Mottet N, Lam TB, Rouvière O.

Eur Urol. 2017 Aug;72(2):250-266. doi: 10.1016/j.eururo.2017.02.026. Epub 2017 Mar 21. Review.

PMID:
28336078
3.

Comparison of Prostate Biopsy with or without Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: An Observational Cohort Study.

Bryant RJ, Hobbs CP, Eyre KS, Davies LC, Sullivan ME, Shields W, Sooriakumaran P, Verrill CL, Gleeson FV, MacPherson RE, Hamdy FC, Brewster SF.

J Urol. 2019 Mar;201(3):510-519. doi: 10.1016/j.juro.2018.09.049.

PMID:
30266332
4.

AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer.

Fulgham PF, Rukstalis DB, Turkbey IB, Rubenstein JN, Taneja S, Carroll PR, Pinto PA, Bjurlin MA, Eggener S.

J Urol. 2017 Oct;198(4):832-838. doi: 10.1016/j.juro.2017.04.101. Epub 2017 May 5. Review.

PMID:
28483574
5.

Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer.

Mortezavi A, Märzendorfer O, Donati OF, Rizzi G, Rupp NJ, Wettstein MS, Gross O, Sulser T, Hermanns T, Eberli D.

J Urol. 2018 Aug;200(2):309-318. doi: 10.1016/j.juro.2018.02.067. Epub 2018 Feb 21.

PMID:
29474846
6.

The Diagnostic Performance of Multiparametric Magnetic Resonance Imaging to Detect Significant Prostate Cancer.

Thompson JE, van Leeuwen PJ, Moses D, Shnier R, Brenner P, Delprado W, Pulbrook M, Böhm M, Haynes AM, Hayen A, Stricker PD.

J Urol. 2016 May;195(5):1428-1435. doi: 10.1016/j.juro.2015.10.140. Epub 2015 Oct 31.

PMID:
26529298
7.

Prostate Cancer Diagnosis on Repeat Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy of Benign Lesions: Recommendations for Repeat Sampling.

Chelluri R, Kilchevsky A, George AK, Sidana A, Frye TP, Su D, Fascelli M, Ho R, Abboud SF, Turkbey B, Merino MJ, Choyke PL, Wood BJ, Pinto PA.

J Urol. 2016 Jul;196(1):62-7. doi: 10.1016/j.juro.2016.02.066. Epub 2016 Feb 13.

PMID:
26880408
8.

Which Patients with Negative Magnetic Resonance Imaging Can Safely Avoid Biopsy for Prostate Cancer?

Oishi M, Shin T, Ohe C, Nassiri N, Palmer SL, Aron M, Ashrafi AN, Cacciamani GE, Chen F, Duddalwar V, Stern MC, Ukimura O, Gill IS, Luis de Castro Abreu A.

J Urol. 2019 Feb;201(2):268-276. doi: 10.1016/j.juro.2018.08.046.

9.

Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?

Delongchamps NB, Lefèvre A, Bouazza N, Beuvon F, Legman P, Cornud F.

J Urol. 2015 Apr;193(4):1198-204. doi: 10.1016/j.juro.2014.11.002. Epub 2014 Nov 11.

PMID:
25451824
10.

Multiparametric magnetic resonance imaging: Current role in prostate cancer management.

Ueno Y, Tamada T, Bist V, Reinhold C, Miyake H, Tanaka U, Kitajima K, Sugimura K, Takahashi S.

Int J Urol. 2016 Jul;23(7):550-7. doi: 10.1111/iju.13119. Epub 2016 May 17. Review.

11.
12.

Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer.

Rais-Bahrami S, Siddiqui MM, Turkbey B, Stamatakis L, Logan J, Hoang AN, Walton-Diaz A, Vourganti S, Truong H, Kruecker J, Merino MJ, Wood BJ, Choyke PL, Pinto PA.

J Urol. 2013 Nov;190(5):1721-1727. doi: 10.1016/j.juro.2013.05.052. Epub 2013 May 29.

13.

Prostate Cancer: The European Society of Urogenital Radiology Prostate Imaging Reporting and Data System Criteria for Predicting Extraprostatic Extension by Using 3-T Multiparametric MR Imaging.

Kayat Bittencourt L, Litjens G, Hulsbergen-van de Kaa CA, Turkbey B, Gasparetto EL, Barentsz JO.

Radiology. 2015 Aug;276(2):479-89. doi: 10.1148/radiol.15141412. Epub 2015 Apr 3.

PMID:
25848900
14.

Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma.

Prendeville S, Gertner M, Maganti M, Pintilie M, Perlis N, Toi A, Evans AJ, Finelli A, van der Kwast TH, Ghai S.

J Urol. 2018 Jul;200(1):104-113. doi: 10.1016/j.juro.2018.01.081. Epub 2018 Feb 2.

PMID:
29408568
15.

High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy.

Komai Y, Numao N, Yoshida S, Matsuoka Y, Nakanishi Y, Ishii C, Koga F, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K.

J Urol. 2013 Sep;190(3):867-73. doi: 10.1016/j.juro.2013.03.078. Epub 2013 Mar 28.

PMID:
23542406
16.

The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.

Recabal P, Assel M, Sjoberg DD, Lee D, Laudone VP, Touijer K, Eastham JA, Vargas HA, Coleman J, Ehdaie B.

J Urol. 2016 Aug;196(2):374-81. doi: 10.1016/j.juro.2016.02.084. Epub 2016 Feb 23.

17.

Diagnostic Value of Cognitive-Registration Multiparametric Magnetic Resonance Guided Biopsy for the Detection of Prostate Cancer after Initial Negative Biopsy.

Tomašković I, Pezelj I, Bolanča Čulo K, Novosel L, Nikles S, Tomić M, Reljić A, Katušić J, Knežević M, Pirša M, Kruslin B, Ulamec M, Ružić B.

Acta Clin Croat. 2018 Oct;57(Suppl 1):40-45. doi: 10.20471/acc.2018.57.s1.05.

PMID:
30457246
18.

Risk Stratification of Equivocal Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate.

Ullrich T, Quentin M, Arsov C, Schmaltz AK, Tschischka A, Laqua N, Hiester A, Blondin D, Rabenalt R, Albers P, Antoch G, Schimmöller L.

J Urol. 2018 Mar;199(3):691-698. doi: 10.1016/j.juro.2017.09.074. Epub 2017 Sep 20.

PMID:
28941924
19.

Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting.

Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, Heijmink SW, Hoskin PJ, Kirkham A, Padhani AR, Persad R, Puech P, Punwani S, Sohaib AS, Tombal B, Villers A, van der Meulen J, Emberton M.

Eur Urol. 2011 Apr;59(4):477-94. doi: 10.1016/j.eururo.2010.12.009. Epub 2010 Dec 21.

PMID:
21195536
20.

Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.

Thompson JE, Moses D, Shnier R, Brenner P, Delprado W, Ponsky L, Pulbrook M, Böhm M, Haynes AM, Hayen A, Stricker PD.

J Urol. 2014 Jul;192(1):67-74. doi: 10.1016/j.juro.2014.01.014. Epub 2014 Feb 8.

PMID:
24518762

Supplemental Content

Support Center